Reaktion #155910

ord-10e29d74cf0148fcbd6fe1efe2fa5d55

Reaktionsgleichung

Cc1nn(-c2ccccc2)c2nc(C3CCNCC3)[nH]c(=O)c12.Cl
3-methyl-1-phenyl-6-(piperidin-4-yl)-1H-pyrazolo[3,4-d]pyrimidin-4(5H)-one hydrochloride
CC(C)(C)OC(=O)N1CCC(=O)C1
tert-butyl 3-oxopyrrolidine-1-carboxylate
[BH3-]C#N.[Na+]
NaBH3CN
Cc1nn(-c2ccccc2)c2nc(C3CCN(C4CCN(C(=O)OC(C)(C)C)C4)CC3)[nH]c(=O)c12
tert-butyl 3-(4-(3-methyl-4-oxo-1-phenyl-4,5-dihydro-1H-pyrazolo[3,4-d]pyrimidin-6-yl)piperidin-1-yl)pyrrolidine-1-carboxylate

Lösungsmittel

Reaktionsbedingungen

Detaillierte Bedingungen
See reaction.notes.procedure_details.

Aufarbeitung

  1. 1
    SonstigeInto a 100-mL round-bottom flask, was placed
  2. 2
    Sonstigeat room temperature
  3. 3
    Sonstigeat room temperature
  4. 4
    EinengenThe resulting mixture was concentrated under vacuum
  5. 5
    workup.DISSOLUTIONThe residue was dissolved in water (50 mL)
  6. 6
    ExtraktionThe resulting solution was extracted with ethyl acetate (3×50 mL)
  7. 7
    Einengenconcentrated under vacuum

Vorschrift

Into a 100-mL round-bottom flask, was placed a solution of 3-methyl-1-phenyl-6-(piperidin-4-yl)-1H-pyrazolo[3,4-d]pyrimidin-4(5H)-one hydrochloride (500 mg, 1.45 mmol, 1.00 equiv) in methanol (50 mL) at room temperature. To the resulting mixture was then added tert-butyl 3-oxopyrrolidine-1-carboxylate (804 mg, 4.35 mmol, 3.00 equiv), in portions at room temperature, followed by NaBH3CN (456 mg, 7.24 mmol, 5.00 equiv) at room temperature. The resulting solution was stirred overnight at room temperature. The resulting mixture was concentrated under vacuum. The residue was dissolved in water (50 mL). The resulting solution was extracted with ethyl acetate (3×50 mL), the organic layers combined and concentrated under vacuum to yield tert-butyl 3-(4-(3-methyl-4-oxo-1-phenyl-4,5-dihydro-1H-pyrazolo[3,4-d]pyrimidin-6-yl)piperidin-1-yl)pyrrolidine-1-carboxylate as a white solid.

Quelle

DOI: 10.6084/m9.figshare.5104873.v1Patent: US08822447B2uspto-grants-2014_09